ADARx Pharmaceuticals Statistics
Total Valuation
ADRX has a market cap or net worth of $1.98 billion. The enterprise value is $1.56 billion.
| Market Cap | 1.98B |
| Enterprise Value | 1.56B |
Important Dates
The next estimated earnings date is Sunday, November 15, 2026, after market close.
| Earnings Date | Nov 15, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ADRX has 112.06 million shares outstanding.
| Current Share Class | 112.06M |
| Shares Outstanding | 112.06M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +0.04% |
| Owned by Insiders (%) | 12.70% |
| Owned by Institutions (%) | 3.20% |
| Float | 46.10M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 323.26 |
| Forward PS | n/a |
| PB Ratio | 18.59 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 254.65 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 12.98, with a Debt / Equity ratio of 0.06.
| Current Ratio | 12.98 |
| Quick Ratio | 12.56 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -25.17% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | $61,270 |
| Profits Per Employee | -$878,700 |
| Employee Count | 100 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | n/a |
| Average Volume (20 Days) | 1,248,080 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ADRX had revenue of $6.13 million and -$87.87 million in losses. Loss per share was -$7.74.
| Revenue | 6.13M |
| Gross Profit | -83.74M |
| Operating Income | -106.30M |
| Pretax Income | -87.87M |
| Net Income | -87.87M |
| EBITDA | -105.12M |
| EBIT | -106.30M |
| Loss Per Share | -$7.74 |
Balance Sheet
The company has $427.25 million in cash and $6.90 million in debt, with a net cash position of $420.35 million or $3.75 per share.
| Cash & Cash Equivalents | 427.25M |
| Total Debt | 6.90M |
| Net Cash | 420.35M |
| Net Cash Per Share | $3.75 |
| Equity (Book Value) | 106.57M |
| Book Value Per Share | -22.16 |
| Working Capital | 407.53M |
Cash Flow
In the last 12 months, operating cash flow was -$88.32 million and capital expenditures -$1.89 million, giving a free cash flow of -$90.21 million.
| Operating Cash Flow | -88.32M |
| Capital Expenditures | -1.89M |
| Depreciation & Amortization | 1.18M |
| Net Borrowing | n/a |
| Free Cash Flow | -90.21M |
| FCF Per Share | -$0.81 |
Margins
| Gross Margin | n/a |
| Operating Margin | -1,734.98% |
| Pretax Margin | -1,434.14% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ADRX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -4.44% |
| FCF Yield | -4.55% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ADRX has an Altman Z-Score of -0.51. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.51 |
| Piotroski F-Score | n/a |